With an estimated 6.8 million U.S. citizens requiring mobility devices to aid in walking or to improve mobility, the need for long-term solutions is ever-increase. Yes, mobility devices offer the much-needed help, but they aren’t a panacea to the prevailing issue. Technological milestones have allowed for the use of what’s known as a viable bone matrix to offer a lasting solution.
Delving into Viable Bone Matrix Treatment
Viable bone matrix treatment incorporates bone grafting using allogenic (tissue from genetically different individuals of the same species) bone grafts as a method of enhancing bone repair and regeneration.
The bone matrix contains several human-origin bone-forming cells including mesenchymal stem cells (MSCs) that are necessary for bone repair and remodeling. These MSCs promote healing and repair by differentiating into bone cells that make new bones.
Bone graft surgery involves the transplantation of bone tissue and is a procedure that makes this treatment a possibility. Typically, during the surgery, the orthopedic surgeon takes a piece of the allograft and places it where a bone needs to heal. The healing potential of this procedure has been a source of therapeutic solutions, helping many patients with mobility issues regain mobility and achieve a better quality of life.
How Advancements in Bone Grafting Technology Are Helping
Technological milestones present a step-forward more so in the field of medicine. Better technologies mean more efficient therapeutic methods. Some diseases of the bone such as osteonecrosis or bone cancer might warrant bone grafts after the initial surgery in which the damaged or diseased part of the bone is removed.
When weighing the risk-versus-reward factor of bone grafts, the odds are highly tilted towards the reward outcome. For those 6.8 million individuals living with mobility issues, having a bone graft could be a life-changer. Aging or traumatized joints and bones could be replaced to promote a return to normal mobility and therefore enhance better life quality.
When it comes to allogenic bone grafting, no added surgery is necessary to acquire the bone thereby lowering the risk of infection. Additionally, given the fact that the viable bone matrix entails the use of mesenchymal stem cells, the chances of rejection are significantly lowered. This implies less need for large doses of immunosuppressants that typically put the patient at risk of contracting other opportunistic illnesses.
For patients who suffer from pain alongside a loss of mobility, opioids such as fentanyl, have been the go-to source of relief. Bone grafts for such patients could help eliminate suffering while also preventing opioid reliance.
For top of the range instruments and new technology in the field of orthopedics, you need to seek the services of a company that specializes in medical instruments for safe, unique, and affordable healthcare solutions. SurGenTech is a great example that plays a key role in the orthopedic industry to deliver optimal quality of life to patients from all walks of life.